1. Home
  2. BOLD vs BODI Comparison

BOLD vs BODI Comparison

Compare BOLD & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BODI
  • Stock Information
  • Founded
  • BOLD 2018
  • BODI 1998
  • Country
  • BOLD United States
  • BODI United States
  • Employees
  • BOLD N/A
  • BODI N/A
  • Industry
  • BOLD
  • BODI Industrial Machinery/Components
  • Sector
  • BOLD
  • BODI Industrials
  • Exchange
  • BOLD Nasdaq
  • BODI Nasdaq
  • Market Cap
  • BOLD 24.4M
  • BODI 25.4M
  • IPO Year
  • BOLD 2024
  • BODI N/A
  • Fundamental
  • Price
  • BOLD $1.19
  • BODI $4.55
  • Analyst Decision
  • BOLD Buy
  • BODI Buy
  • Analyst Count
  • BOLD 3
  • BODI 2
  • Target Price
  • BOLD $4.00
  • BODI $10.00
  • AVG Volume (30 Days)
  • BOLD 105.5K
  • BODI 16.8K
  • Earning Date
  • BOLD 08-11-2025
  • BODI 08-05-2025
  • Dividend Yield
  • BOLD N/A
  • BODI N/A
  • EPS Growth
  • BOLD N/A
  • BODI N/A
  • EPS
  • BOLD N/A
  • BODI N/A
  • Revenue
  • BOLD N/A
  • BODI $371,113,000.00
  • Revenue This Year
  • BOLD N/A
  • BODI N/A
  • Revenue Next Year
  • BOLD N/A
  • BODI N/A
  • P/E Ratio
  • BOLD N/A
  • BODI N/A
  • Revenue Growth
  • BOLD N/A
  • BODI N/A
  • 52 Week Low
  • BOLD $1.00
  • BODI $3.38
  • 52 Week High
  • BOLD $4.72
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • BODI 60.10
  • Support Level
  • BOLD N/A
  • BODI $3.81
  • Resistance Level
  • BOLD N/A
  • BODI $4.79
  • Average True Range (ATR)
  • BOLD 0.00
  • BODI 0.30
  • MACD
  • BOLD 0.00
  • BODI 0.06
  • Stochastic Oscillator
  • BOLD 0.00
  • BODI 62.73

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: